Delta Asia International Corporation (TPEX:6762)
265.00
+4.00 (1.53%)
May 14, 2025, 1:01 PM CST
Delta Asia International Revenue
Delta Asia International had revenue of 163.63M TWD in the quarter ending March 31, 2025, with 63.14% growth. This brings the company's revenue in the last twelve months to 643.84M, up 42.70% year-over-year. In the year 2024, Delta Asia International had annual revenue of 580.51M with 14.27% growth.
Revenue (ttm)
643.84M
Revenue Growth
+42.70%
P/S Ratio
12.38
Revenue / Employee
3.52M
Employees
183
Market Cap
7.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 580.51M | 72.49M | 14.27% |
Dec 31, 2023 | 508.02M | 45.05M | 9.73% |
Dec 31, 2022 | 462.97M | -68.34M | -12.86% |
Dec 31, 2021 | 531.32M | -23.00M | -4.15% |
Dec 31, 2020 | 554.31M | 170.94M | 44.59% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |